Compared to Estimates, Immunocore (IMCR) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
2 weeks ago • Google News
Immunocore Holdings Ltd (IMCR)
US$ 34.691.11%
Price Chart
Key Statistics
Market Cap
$ 1.39B
P/E Ratio
0.00
Revenue (TTM)
$ 333.58M
Volume
199.47K
52W High
$ 55.07
52W Low
$ 23.15
Dividend Yield
0.00%
Beta
0.75
Technicals
50-Day MA
28.9481
200-Day MA
31.524
52 Week High
55.07
52 Week Low
23.15
About IMCR
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KI.
Employees
493
Headquarters
Abingdon, United Kingdom
CEO
Dr. Bahija Jallal Ph.D.
Latest News
Immunocore Holdings (IMCR) Sees Price Target Boost from Oppenhei - GuruFocus
6 days ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg